Mesenchymal stromal cells ameliorate diabetes‐induced muscle atrophy through exosomes by enhancing AMPK/ULK1‐mediated autophagy

• Main Authors: Jia Song (Author), Jidong Liu (Author), Chen Cui (Author), Huiqing Hu (Author), Nan Zang (Author), Mengmeng Yang (Author), Jingwen Yang (Author), Ying Zou (Author), Jinquan Li (Author), Lingshu Wang (Author), Qin He (Author), Xinghong Guo (Author), Ruxing Zhao (Author), Fei Yan (Author), Fuqiang Liu (Author), Xinguo Hou (Author), Zheng Sun (Author), Li Chen (Author)
• Format: Book
• Published: Wiley, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Diabetes and obesity are associated with muscle atrophy that reduces life quality and lacks effective treatment. Mesenchymal stromal cell (MSC)‐based therapy can ameliorate high fat‐diet (HFD) and immobilization (IM)‐induced muscle atrophy in mice. However, the effect of MSCs on...